Limited coverage drugs – cilazapril

Last updated on August 20, 2024

Generic name          

cilazapril, including in combination with hydrochlorothiazide                                                                                                     

Strength

1 mg, 2.5 mg, 5 mg, 5 mg/12.5 mg

Form

tablet

Special Authority criteria

Approval period

  1. Treatment failure on optimal doses of or intolerance to ramipril

      OR

  1. Complex patient requiring medication(s) for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

  • Practitioners in the following specialties are not required to submit a Special Authority request for coverage:
    • paediatric cardiology
    • paediatrics

Special notes

  • Individuals requiring a diuretic combination product must satisfy the same criteria.
  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.

Special Authority requests